A 31 year-old male was admitted with objective vertigo and gait disturbance of one month of duration. The magnetic resonance image showed supratentorial and infratentorial gadolinium-enhaced lesions. The symptoms got worse later, developing a Bell’s palsy and a right internuclear ophthalmoplegia. Visual evoked response came abnormal, the auditive’s, normal. Anticardiolipin IgM antibodies became strongly positive, but in a second intent, they resulted negative. Cerebrovascular disease of young adults and thrombophilia were rejected because of negative results on tests like Protein C, C3, C4, Antithrombin III. The treatment with methylprednisolone made him feel better. There are still pending the laboratory results for oligoclonal bands in cerebrospinal luid and space and time results of a new magnetic resonance. Dissemination of lesions in space of the McDonald criteria were fulilled and it was concluded that the definitive diagnosis was Multiple Sclerosis. The discharged treatment was ?-interferon 1b with diphenhydramine and acetaminophen.
Downloads
Download data is not yet available.
References
Harrison, T. Principios de Medicina Interna. 16ª ed. México D.F: McGraw Hill; 2005.
Olek M. Diagnóstico de la Esclerosis Múltiple en Adultos. In: Up-to-date. Versión 15.2, Abril, 2007 [Octubre 2007]. Disponible en: http://www.uptodate.com/
Nosewhorty et al. Multiple sclerosis. N Engl J Med 2000; 343 (13): 938-952.
Stedman’s Medical Dictionary. 28ª ed. Estados Unidos: Lippincott, Williams and Wilkins; 2005.
Rengachary D. The Washington Manual Neurology Survival Guide. Versión 6.0.7. St. Louis, Estados Unidos: Lippincott, Williams and Wilkins; 2004.
Venes D. Taber’s Cyclopedic Medical Dictionary. 20ª ed. Estados Unidos: F.A. Davis Company; 2005.
Peltonen L. Old Suspects Found Guilty- The first genome profile for multiple sclerosis. N Engl J Med 2007; 357(9): 927-929.
Haler et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357 (9): 851-862.
Greer D et al. Case 21-2001: a 58 year old woman with headaches, weakness, and stroke-like episodes. N Engl J Med 2007; 357(2): 164-173.
Lynn D, Newton H, Rae-Grant A. The 5-Minute Neurology Consult. Versión 7.0.7. Estados Unidos: Lippincott, Williams and Wilkins; 2004.
Fernández-Fernández et al. Respuesta al interferón beta en la esclerosis múltiple asociada con la discapacidad previa al tratamiento. Rev Neurol 2006; 43 (6): 322-329.
Frohman et al. Esclerosis múltiple - La placa y su patogénesis. N Engl J Med 2006; 354: 942-955.
Kumar V, Abbas A, Fausto N. Robbins y Cotran. Patología estructural y funcional. 7ª ed. España: Elsevier 2006.
Gracia et al. Epidemiología de la Esclerosis Múltiple en Panamá.
Herrera et al. Parental transmission of MS in a population-based Canadian cohort. Neurology. 2007; 69: 1208-1212.
Dorlands’s Pocket Medical Dictionary. 30ª ed. Estados Unidos: Saunders, Elsevier Science; 2004.
Hopper Deglin J, Hazard Vallerand A. Davis’s Drug Guide for Physicians (Dr. Drugs). Versión 9.3.9. Estados Unidos: F. A. Davis Company; 2006.
